Blu Pharma plans expansion at new Puerto Rico plant
Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
Capacity at Blu Pharmaceutical’s recently acquired solid dosage production plant in Puerto Rico is set to expand considerable over the next three years according to company president Bill Luster.
Ajinomoto AminoScience has launched AjiPhase, a peptide synthesis service which makes it practical and efficient to produce and scale up products that were previously considered too complex.
A project bringing together researchers from academia and pharma companies, including GSK and AZ, has received a £709,000 ($1.09m) grant to create crystals using continuous flow production.
eBizNET has entered into a strategic relationship with CDC Software, which is expected to accelerate the deployment of its SaaS supply chain systems in emerging, high growth markets.
Demand in “Pharmerging” markets will offset declining revenues from off-patent blockbusters and drive prescription drug sales to $1.1tr (€819bn) by 2014, according to IMS Health.
Pfizer failed to ensure proper monitoring of a clinical trial in which in number of patients received overdoses, according to the US Food and Drug Administration (FDA).
Indian CRO Siro Clinpharm says partnering with Taiwanese counterpart Virginia Contract Research Organisation (VCRO) furthers its geographical reach and access to patients.